Detalhe da pesquisa
1.
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update.
Blood
; 143(17): 1713-1725, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194692
2.
Assessment of Healthcare Resource Utilization and Hospitalization Costs in Patients With Relapsed or Refractory Follicular Lymphoma Undergoing CAR-T Cell Therapy With Tisagenlecleucel: Results From the ELARA Study.
Transplant Cell Ther
; 29(1): 60.e1-60.e4, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36182104
3.
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial.
Nat Med
; 28(2): 325-332, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34921238